A new strategy to cure disease in a single day, and forever: epigenetic silencing
By Manuel Ansede,
El País
| 03. 01. 2024
A team of Italian researchers has reached a major scientific milestone, heralding a revolution in the field of medicine. The scientists have succeeded in silencing a gene associated with high cholesterol levels, without the need to modify DNA. In the experiment, which was conducted on mice, the effects of the gene silencing persisted for the entire year that the experiment lasted — a period equivalent to half an average human life. These results suggest that it may be possible to solve chronic health problems, permanently, and in a single day of treatment. The study was published this Wednesday in the journal Nature, a leading reference in the world of science.
DNA is like a book, with some 3 billion chemical letters, that provides instructions for the functioning of every cell. This immense text is divided into pages — the genes — which contain specific recipes for making the proteins necessary for life: the collagen in cartilage, the hemoglobin in blood, the antibodies that fight pathogens. One of these genes, PCSK9, contains guidelines for producing a protein associated with...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Ewen Callaway, Nature | 08.04.2025
For months, researchers in a laboratory in Dallas, Texas, worked in secrecy, culturing grey-wolf blood cells and altering the DNA within. The scientists then plucked nuclei from these gene-edited cells and injected them into egg cells from a domestic dog ...
By Kristel Tjandra, Genetic Engineering & Biotechnology News | 07.30.2025
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on various fronts. But getting CRISPR experiments right in the lab isn’t simple...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...